Graviti Pharmaceuticals Private Limited FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Jul 28, 2026
  • No warning letters matched by name
Inspections 2 0 OAI
Recalls 3 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Graviti Pharmaceuticals Private Limited has 3 FDA recalls, 2 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Graviti Pharmaceuticals Private Limited" is on file.

What these totals cover: FDA records filed under the name "Graviti Pharmaceuticals Private Limited".

Latest recall
D-0293-2026 · Class II · Jan 10, 2026
Latest inspection
Jul 28, 2026 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls3Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections2Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Graviti Pharmaceuticals Private Limited's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Graviti Pharmaceuticals Private Limited: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2026: 1 inspection (0 OAI), 0 warning letters, 1 recall record (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202610010
202500010
202400000
202310000
202200000
202100000
202000010
201900000
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Graviti Pharmaceuticals Private Limited as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Graviti Pharmaceuticals Private Limited yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

3 recall records from Jan 28, 2020 to Jan 10, 2026.

NumberClassProductDate
D-0293-2026Class IIFurosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals…Jan 10, 2026
D-0037-2026Class IIBupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd…Sep 15, 2025
D-0832-2020Class IIAtorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for: Biocon Pharma…Jan 28, 2020

Recent FDA inspections

2 inspections from Feb 3, 2023 to Jul 28, 2026.

DateSiteProductClassificationFEI
Jul 28, 2026Hyderabad, IndiaDrugsVoluntary Action Indicated (VAI)3012932394
Feb 3, 2023Hyderabad, IndiaDrugsNo Action Indicated (NAI)3012932394
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3012932394Hyderabad, India2Jul 28, 2026

Graviti Pharmaceuticals Private Limited and the FDA: common questions

Has Graviti Pharmaceuticals Private Limited received an FDA warning letter?

No FDA warning letter addressed to the name "Graviti Pharmaceuticals Private Limited" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Graviti Pharmaceuticals Private Limited received an FDA Form 483?

FDA has not published a Form 483 for "Graviti Pharmaceuticals Private Limited" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Graviti Pharmaceuticals Private Limited?

The most recent FDA inspection on file ended Jul 28, 2026 at Hyderabad, India and was classified VAI. FDA has 2 inspections of Graviti Pharmaceuticals Private Limited on file.

Has Graviti Pharmaceuticals Private Limited had an FDA recall?

Yes. Graviti Pharmaceuticals Private Limited has 3 FDA recalls on record. The most recent started Jan 10, 2026.

Need more than this page shows? Ask about Graviti Pharmaceuticals Private Limited in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.